CD8+T Cells Activated Using a Low Affinity MHC Class I Ligand From Tyrosinase Related Protein 1 Lead to Tumor Rejection

被引：0
|
作者：
Povelko, Kevin D. [1 ]
Hansen, Michael J. [1 ]
Pease, Larry R. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF IMMUNOTHERAPY | 2008年 / 31卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：947 / 947
页数：1
相关论文
共 50 条
  • [1] The role of MHC class I and CD8+T cells in the pathogenesis of chronic rejection.
    Sun, H
    Subbotin, V
    Woodward, JE
    Valdivia, LA
    Fung, JJ
    Rao, AS
    TRANSPLANTATION, 2000, 69 (08) : S352 - S352
  • [2] Vaccination using epitopes with higher MHC class I affinity elicits CD8+T cells with increased PD-1 expression
    Zahm, Christopher D.
    McNeel, Douglas
    CANCER RESEARCH, 2015, 75
  • [3] Tracking Antigen-Specific CD8+T cells Using MHC Class I Pentamers
    Aleksandrovic, Emilija
    Lazarski, Christopher
    Bollard, Catherine
    Stanojevic, Maja
    Hanley, Patrick
    FASEB JOURNAL, 2020, 34
  • [4] A soluble divalent class I MHC/IgG1 fusion protein activates CD8+T cells in vivo
    Carey, B
    DeLay, M
    Strasser, JE
    Chalk, C
    Dudley-McClain, K
    Milligan, GN
    Brunner, HI
    Thornton, S
    Hirsch, R
    CLINICAL IMMUNOLOGY, 2005, 116 (01) : 65 - 76
  • [5] Role of MHC class I and CD8+ T cells in the pathogenesis of chronic rejection
    Sun, H
    Subbotin, V
    Woodward, J
    Valdivia, L
    Fung, JJ
    Rao, AS
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 319 - 319
  • [6] The fate of low affinity tumor-specific CD8+T cells in tumor bearing mice
    Lyman, MA
    Nugent, CT
    Marquardt, KL
    Biggs, JA
    Pamer, EG
    Sherman, LA
    FASEB JOURNAL, 2005, 19 (04): : A361 - A361
  • [7] Antimicrobial activity of MHC class I-restricted CD8+T cells in human tuberculosis
    Cho, S
    Mehra, V
    Thoma-Uszynski, S
    Stenger, S
    Serbina, N
    Mazzaccaro, RJ
    Flynn, JL
    Barnes, PF
    Southwood, S
    Celis, E
    Bloom, BR
    Modlin, RL
    Sette, A
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12210 - 12215
  • [8] Bifunctional peptide-MHC class I antibody fusions selectively activate CD8+T cells to eliminate tumor cells in vivo
    Fischer, C.
    Herting, F.
    Imhof-Jung, S.
    Hoffmann, E.
    Umana, P.
    Klein, C.
    Knoetgen, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S12 - S13
  • [9] Allospecific Rejection of MHC Class I-Deficient Bone Marrow by CD8 T Cells
    Haspot, F.
    Li, H. W.
    Lucas, C. L.
    Fehr, T.
    Beyaz, S.
    Sykes, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (01) : 49 - 58
  • [10] Transfer of peptide-MHC class I complexes from necrotic cells to dendritic cells enhances CD8+T cell activation
    Dolan, Brian P.
    Gibbs, Kenneth D.
    Ostrand-Rosenberg., Suzanne
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S60 - S60
12345